Anxiety Disorders
Evidence-Based Reviews
Treatment-resistant OCD: There’s more we can do
Augmentation strategies may help patients who don’t respond to first-line treatments.
News from the FDA/CDC
Anxiety and depression widespread among arthritis patients
Anxiety is far more common, but depression is more likely to be treated.
Conference Coverage
Sexual assault and harassment linked to hypertension, depression, and anxiety
Women may lack the financial stability to leave abusive work situations.
Commentary
Could group CBT help survivors of Florence?
Supportive, educational, and interactive group therapy might help those suffering from the aftereffects of catastrophic weather events.
From the Journals
Behavioral checklist IDs children at risk of depressive, anxiety disorders
The highest risk was among children with a parental history of mood disorder and baseline CBCL anxiety/depression subsyndromal elevations.
Pearls
The benzodiazepine dilemma
As clinicians, we are faced with a conflict when deciding whether or not to prescribe a benzodiazepine.
Daily News Podcast
Colonoscopy: Should 45 be the new 50?
And how to avoid telemed fraud.
What Your Patients are Hearing
Survivors of sexual abuse cope with stigma
People victimized by Roman Catholic priests describe ostracism from fellow parishioners.
Pearls
Providing culturally competent postpartum care for South Asian women
To improve outcomes for South Asian patients, clinicians should strive to provide culturally competent care.
From the Journals
Alopecia areata linked to mental health disorders
Inpatients with alopecia areata are at higher risk for numerous psychiatric disorders, including anxiety disorders, ADHD, dementia, and mood and...
FDA/CDC
FDA allows marketing of TMS to treat OCD
Transcranial magnetic stimulation already is approved to treat refractory major depression and migraine with aura.